Lenka Stolarova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Case-Control Study for 23 Cancer Types With Functional Analysis of CHEK2: Risk Estimation and Clinical Recommendations in East Asia.

Case-Control Study for 23 Cancer Types With Functional Analysis of CHEK2: Risk Estimation and Clinical Recommendations in East Asia.

Journal: JCO precision oncology

Published: September 02, 2025

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.

Journal: Cancer medicine

Published: February 15, 2024

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 28, 2023

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

Journal: Cells

Published: November 15, 2020

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes.

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes.

Journal: Biomedicines

Published: August 31, 2020

Phosphorylation of PLK3 Is Controlled by Protein Phosphatase 6.

Phosphorylation of PLK3 Is Controlled by Protein Phosphatase 6.

Journal: Cells

Published: May 15, 2020

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.

Journal: Cancers

Published: March 15, 2020

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 15, 2019

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 15, 2019

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.

Journal: Cancers

Published: March 28, 2019

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer.

Journal: International journal of cancer

Published: February 06, 2019

BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.

BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.

Journal: Human mutation

Published: April 16, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026